Page last updated: 2024-08-23

bezafibrate and Hepatitis, Autoimmune

bezafibrate has been researched along with Hepatitis, Autoimmune in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hasegawa, S; Honda, Y; Hosono, K; Kurita, Y; Nakajima, A; Nogami, A; Yoneda, M1
Abe, K; Kanno, Y; Katsushima, F; Monoe, K; Ohira, H; Saito, H; Takahashi, A; Yokokawa, J1

Reviews

1 review(s) available for bezafibrate and Hepatitis, Autoimmune

ArticleYear
Cholestatic Liver Disease: Current Treatment Strategies and New Therapeutic Agents.
    Drugs, 2021, Volume: 81, Issue:10

    Topics: Anti-Bacterial Agents; Bezafibrate; Cholagogues and Choleretics; Cholangitis, Sclerosing; Fibroblast Growth Factors; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Peroxisome Proliferator-Activated Receptors; Probiotics; Receptors, Cytoplasmic and Nuclear; Tumor Necrosis Factor-alpha

2021

Other Studies

1 other study(ies) available for bezafibrate and Hepatitis, Autoimmune

ArticleYear
Case of primary biliary cirrhosis-autoimmune hepatitis overlap which manifested after delivery.
    Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:12

    Topics: Adult; Bezafibrate; Cholagogues and Choleretics; Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Postpartum Period; Pregnancy; Ursodeoxycholic Acid

2011